| Application no. and date | 16180926.4 (espacenet) (Federated) (European Patent Register), 20081223 | | Patent/reg. no. and date | DK/EP 3109258, 20190123 | | Publication date | 20161228 | | Priority no. and date | US 16524 P, 20071224, US 56206 P, 20080527 | | EP pub. no. and date |
EP 3109258 20161228 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals s.a., rue de l'Institut 89
1330 Rixensart, BE,
ID Biomedical Corporation of Quebec, 2323 Boul. du Parc Technologique
Ste Foy
Quebec G1P 4R8, CA | | Applicant ref. no. | | | Inventor | BLAIS, Normand, 525 Cartier Quest
Laval, Québec H6V 3S8, CA,
BAUDOUX, Jean-Pierre, Rue de l'Institut 89
1330 Rixensart, BE,
RHEAULT, Patrick, 525 Cartier Ouest
Laval, Québec H7V 3S8, CA,
RUELLE, Jean-Loius, Rue de l'Institut 89
1330 Rixensart, BE | | Representative | | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/12 (2006.01) , A61K 39/155 (2006.01) , A61K 39/295 (2006.01) , A61K 9/107 (2006.01) , A61K 9/127 (2006.01) , A61P 31/14 (2006.01) , A61P 37/04 (2006.01) , C07K 14/005 (2006.01) , C07K 14/135 (2006.01) , C07K 19/00 (2006.01) , C12N 15/45 (2006.01) , C12N 15/62 (2006.01) | | Title | RECOMBINANT RSV ANTIGENS | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
